Amyloid β (Aβ) and tau pathologies are classic characteristic features of Alzheimer’s disease (AD), and they are widely used as diagnostic biomarkers [1]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.